Hepatitis B virus and HIV coinfection

AIDS Reader

Volumn 12, Issue 10, 2002, Pages 443-451

  Piliero, Peter J ^a   Faragon, John J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cirrhosis; Hepatitis B; Hepatocellular carcinoma; HIV AIDS

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA2B INTERFERON; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; SAQUINAVIR; STAVUDINE; ZIDOVUDINE; ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DRUG CHOICE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; TREATMENT PLANNING; FATALITY; LIVER TUMOR; MIDDLE AGED;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FATAL OUTCOME; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0036781229     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492-497.
2. Befeler AS, Di Bisceglie AM. Hepatitis B. Infect Dis Clin North Am. 2000;14:617-632.
3. McNair AN, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis. 1992,12:188-196.
4. Gordon SC, Reddy KR, Gould EE, et al. The spectrum of liver disease in the acquired immunodeficiency syndrome. J Hepatol. 1986;2:475-484.
5. Lebovics E, Dworkin BM, Heier SK, Rosenthal WS. The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol. 1988;83:1-7.
6. Berger A, Preiser W, Doerr HW. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol. 2001;20:23-30.
7. Chung RT, Kim AY, Polsky B. HIV/hepatitis B and C co-infection: pathogenic interactions, natural history, and therapy. Antivir Chem Chemother. 2001;12(suppl 1):73-91.
8. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis. 1991;163:454-459.
9. Collier AC, Corey L, Murphy VL, et al. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med. 1988;109:101-105.
10. Lazizi Y, Grangeot-Keros L, Delfraissy JF, et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. J Infect Dis. 1988;158:666-667.
11. Bonacini M, Govindarajan S, Redeker AG. Human immunodeficiency virus infection does not alter serum transaminases and hepatitis B virus (HBV) DNA in homosexual patients with chronic HBV infection. Am J Gastroenterol. 1991;86:570-573.
12. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994;17:71-91.
13. Cropley I, Main J. Hepatitis C virus infection: coinfection with HIV and HBV. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:265-275.
14. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-1745.
15. Nevens F, Main J, Honkoop P, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology. 1997;113:1258-1263.
16. Dore GJ, Cooper DA, Barrett C, et al. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee. J Infect. Dis. 1999;180:607-613.
17. Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med. 1999;341:1256-1263.
18. Regev A, Schiff ER. Drug therapy for hepatitis B. Adv Intern Med. 2001;46:107-135.
19. Altfeld M, Rockstroh JK, Addo M, et al. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol. 1998;29:306-309.
20. Honkoop P, de Man RA, Niesters HG, et al. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy. Hepatology. 2000;32:635-639.
21. Schnittman SM, Pierce PF. Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type. Clin Infect Dis. 1996;23:638-639.
22. Fischer KP, Gutfreund KS, Tyrrell DL. Lamivudine resistance in hepatitis B: mechanisms and clinical implications. Drug Resist Updat. 2001;4:118-128.
23. Bonaci M, Kurz A, Locarnini S, et al. Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV. Gastroneterology. 2002;122:244-245.
24. Kim JW, Lee HS, Woo GH, et al. Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-motif mutation of hepatitis B virus after]ong-term lamivudine therapy. Clin Infect Dis. 2001;33:403-405.
25. Cooper D, Cheng A, Coakley D, et al. Anti-HBV activity of tenofovir disoproxil fumarate (TDF) in lamivudine (LAM) experienced HIV/HBV co-infected. In: Program and abstracts of the 9th Annual Retrovirus Conference; February 24-28, 2002; Seattle. Abstract 124.
26. Bochet M, Tubiana R, Benhamou Y, et al. Tenofovir disoproxil fumarate suppresses lamivudine resistant HBV replication in patients co-infected with HIV/HBV. In: Program and abstracts of the 9th Annual Retrovirus Conference; February 24-28, 2002; Seattle. Abstract 675-M.
27. Benhamou Y, Bochet M, Thibault V, et al. Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study. Lancet. 2001;358:718-723.
28. Perrillo R, Schiff E, Yoshida E, at al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology. 2000;32:129-134.
29. Marcellin P, Chang TT, Lim SG, et al. A double-blind randomized, placebo controlled study of adefovir dipivoxil for the treatment of patients with HBeAg+ chronic hepatitis B infection: 48 week results [abstract]. Hepatology. 2001;34:A447.
30. Roland M, Stock P, Carlson L, et al. Liver and kidney transplantation in HIV-infected patients: a preliminary multi-site experience. In: Program and abstracts of the 9th Annual Retrovirus Conference; February 24-28, 2002; Seattle. Abstract 655-M.
31. Centers for Disease Control and Prevention. Viral hepatitis B. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/b/Bserology.htm. Accessed August 8, 2002.